Oramed Pharmaceuticals
ORMP
ORMP
17 hedge funds and large institutions have $3.37M invested in Oramed Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $102K
Holders
17
Holding in Top 10
–
Calls
$1K
Puts
$102K
Top Buyers
| 1 | +$75K | |
| 2 | +$11K | |
| 3 | +$7.71K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.42K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$6.38K |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$126K | |
| 3 | -$65K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$57K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$32K |